Key result
Non-hyperemic angiography-derived microcirculatory resistance (NH-IMRangio) was higher in sudden cardiac death survivors with myocardial disease than in those with electrical heart disease.
Why the study?
The management of sudden cardiac death (SCD) involves coronary angiography, and whether the non-hyperemic angiography-derived microcirculatory resistance index (NH-IMRangio) could serve as an easy-to-use tool to distinguish electrical heart disease (EHD) from other causes of SCD was unknown.
Does the non-hyperemic angiography-derived microcirculatory resistance index (NH-IMRangio) distinguish patients with underlying myocardial disease from those with primary electrical heart disease among sudden cardiac death survivors without obstructive coronary artery disease?
Cohort (n=30)
NH-IMRangio analysis performed blinded to clinical data and patient outcomes; visual interpretation of LGE on CMR performed blinded to angiographic results
No
Does the non-hyperemic angiography-derived microcirculatory resistance index (NH-IMRangio) distinguish patients with underlying myocardial disease from those with primary electrical heart disease among sudden cardiac death survivors without obstructive coronary artery disease?
NH-IMRangio derived from routine post-arrest coronary angiography can help differentiate structural myocardial disease from primary electrical heart disease in sudden cardiac death survivors without obstructive CAD, potentially guiding downstream use of cardiac MRI versus electrophysiologic testing.
Answers are grounded in this paper and cite their sources.
NH-IMRangio may aid differentiation of myocardial from electrical disease in SCD survivors without CAD; leaves open prospective validation before guiding testing.
Background: Obstructive coronary disease remains a leading cause of sudden cardiac death (SCD). The management of SCD therefore involves coronary angiography. Our aim was to evaluate whether the non-hyperemic angiography-derived microcirculatory resistance index (NH-IMRangio) could be an easy-to-use tool for identifying patients with electrical heart disease (EHD) from patients with other causes of SCD. Methods: A retrospective study was carried out on 30 patients who survived from SCD with no significant coronary lesions on coronary angiography. Etiological investigations enabled the classification of patients with myocardial disease (Group 1, n=20) and those with EHD without myocardial disease (Group 2, n=10). Myocardial disease was investigated by cardiac magnetic resonance imaging (CMR). NH-IMRangio was determined based on standard coronary angiographic views with 3-dimensional-modeling and computational analysis of the coronary flow. Results: Patients were 46.4±15.9 years old and mostly male (73%). Group 1 included patients with dilated cardiomyopathy (n=7), non-dilated left ventricular cardiomyopathy (n=6), hypertrophic cardiomyopathy (n=2), arrhythmogenic right ventricular cardiomyopathy (n=1), myocardial infarction with non-obstructive coronary arteries (MINOCA) disease due to vasospastic angina (n=1), myocarditis (n=2), chemotherapy-induced cardiomyopathy (n=1). Group 1 presented a significantly higher NH-IMR angio compared to group 2 (46.5±13.1 vs. 34.1±10.8, P<0.02). An NH-IMR angio cut-off of 41.5 enabled an optimal classification of patients with or without myocardial disease. Conclusions: A high NH-IMRangio could represent a useful tool for guiding the etiological diagnosis of SCD towards myocardial disease rather than EHD.
No takes yet. Share an insight, caveat, or question.
Sedoud et al. (2026) conducted a cohort in Sudden cardiac death survivors without obstructive coronary artery disease (n=30). Myocardial disease etiology of sudden cardiac death (evaluated via non-hyperemic angiography-derived index of microcirculatory resistance, NH-IMRangio) vs. Electrical heart disease without myocardial disease was evaluated on Non-hyperemic angiography-derived microcirculatory resistance index (NH-IMRangio) (p=<0.02). Non-hyperemic angiography-derived microcirculatory resistance (NH-IMRangio) was higher in sudden cardiac death survivors with myocardial disease than in those with electrical heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: